Test Price
2,800 AED✅ Home Collection Available
B4GALT1 Gene Sequencing (CDG Type IId) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين B4GALT1 (اضطراب الغلكزة الخلقي النوع IId) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Guaranteed Patient Value
This advanced NGS test delivers 99.9% diagnostic sensitivity for B4GALT1-related Congenital Disorder of Glycosylation Type IId, processed under ISO 9001:2015 certified protocols. التحليل الجيني المتقدم لتشخيص الاضطرابات الخلقية في الغلكزة بدقة 99.9٪ ومعتمد من هيئة الصحة بدبي. Patients receive VIP hospital‑grade home collection (8 AM‑11 PM), cold‑chain logistics, and immediate post‑test clinical guidance via secure tele‑consultation. Direct insurance billing verification is available through WhatsApp +971 54 548 8731.
Test Overview: Why B4GALT1 Sequencing Matters
The B4GALT1 gene encodes an enzyme critical for proper protein glycosylation; pathogenic variants cause CDG Type IId, a multisystem disorder often presenting with severe neurological impairment, hypotonia, and developmental delay. This single‑gene NGS analysis fully sequences the coding regions and splice sites to identify single nucleotide variants, small indels, and copy number changes, giving neurologists and clinical geneticists a definitive molecular diagnosis for targeted management.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Full‑gene NGS with CNV detection (LC‑MS/MS confirmation available) | Sanger sequencing (misses large deletions/duplications) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Sample Options | Whole blood, extracted DNA, or dried blood spot (FTA card) | Often requires fresh blood only |
| Clinical Support | Genetic counselling session + post‑test tele‑guidance | Report only |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA License 61713011, Consultant Neurologist, notes: “Every B4GALT1 result must be interpreted in the context of the patient’s full clinical picture; a negative report does not entirely exclude other glycosylation defects and a VUS requires multidisciplinary correlation. Families should see this test as a pivotal step toward precise management, not an isolated answer.”
Do not discontinue any prescribed medication – including anticonvulsants, neurologically active drugs, or metabolic supplements – without direct consultation with your treating physician.
Exclusion Criteria & Emergency Red Flags
- Do not proceed if the patient is hemodynamically unstable or acutely encephalopathic without physician clearance.
- Ensure mandatory genetic counselling and informed consent prior to sample collection, as recommended by UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) for genetic testing.
- If the patient develops new‑onset seizures, loss of consciousness, or severe respiratory distress at any point, seek emergency medical care immediately – the test does not replace acute clinical evaluation.
Patient FAQ & Clinical Guidance
What does the B4GALT1 gene test detect and why is it ordered?
This test identifies disease‑causing mutations in the B4GALT1 gene, providing a definitive molecular diagnosis for Congenital Disorder of Glycosylation Type IId, which typically manifests with infantile hypotonia, psychomotor delay, and seizures; neurologists and clinical geneticists order it to confirm the etiology and guide personalized treatment.
كيف يتم إجراء الاختبار وما هي طرق جمع العينات المتاحة؟
يتم سحب عينة دم وريدي قياسية أو بقعة دم على بطاقة FTA أو استخدام الحمض النووي المستخلص مسبقًا، ثم تُحلل بتقنية التسلسل الجيني الشامل NGS. Our phlebotomy team uses hospital‑grade cold‑chain transport, and a one‑drop FTA card option is ideal for infants; the entire process is designed for minimal discomfort and maximum sample stability.
How will I receive results and what support is provided?
Your encrypted report is delivered within 3 to 4 weeks via secure portal, and a post‑ tele‑consultation with a clinical genetic counsellor is included to explain the findings, discuss implications for family members, and outline the next clinical steps.
Fully compliant with UAE Federal Decree-Law No. 41 of 2024 (Medical Liability), CDS Law 2026 (Minors), and UAE PDPL (Data Privacy).
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Facility License: 9834453
Direct Billing & Support via WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians